+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Metformin Hydrochloride global market

Metformin Hydrochloride global market

Metformin Hydrochloride Global Market Research 2026

Metformin Hydrochloride Global Market Research 2026 market report providing analysis of industry trends, market dynamics, regional insights, competitive landscape, and growth forecast.

Pages: 220

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Executive Summary

The global Metformin Hydrochloride market represents one of the most stable and volume-driven segments of the pharmaceutical active pharmaceutical ingredient (API) industry. Metformin Hydrochloride remains the first-line oral antidiabetic drug for the treatment of type-2 diabetes, supported by its proven efficacy, safety profile, affordability, and widespread inclusion in national and international treatment guidelines.

In 2025, the global Metformin Hydrochloride market is valued at XX million US$ and is projected to reach XX million US$ by 2036, expanding at a steady CAGR during 2026–2036. Market growth is primarily driven by the rising global prevalence of diabetes, expanding geriatric population, increasing access to generic medicines, and strong demand from emerging economies.

Asia-Pacific, led by India and China, dominates global production due to cost-efficient manufacturing and strong API export capabilities, while North America and Europe remain major consumption markets. Although pricing pressure from generics and regulatory compliance costs pose challenges, long-term demand fundamentals remain highly favorable.

Market Segmentation Analysis

By Product Type

Metformin HCl

  • Core API form used in immediate-release formulations
  • Represents the largest share of global volume consumption
  • High demand from generic tablet manufacturers

Metformin DC (Direct Compression)

  • Pre-processed grade designed for direct tablet compression
  • Enables improved manufacturing efficiency and reduced processing time
  • Increasing adoption among large-scale formulators

Others

  • Includes customized grades and specialty forms
  • Used for specific formulation or regional regulatory requirements

By Application

Metformin Hydrochloride Tablets

  • Dominant application segment
  • High prescription volumes across both developed and developing markets
  • Strong demand from government tenders and public healthcare programs

Metformin Hydrochloride Extended-Release Tablets

  • Fast-growing segment
  • Improved patient compliance and reduced gastrointestinal side effects
  • Increasing preference in chronic diabetes management

Other Forms

  • Includes combination therapies and alternative dosage forms
  • Used in multi-drug diabetes treatment regimens

Key Players Analysis

The Metformin Hydrochloride market is highly competitive and price-sensitive, with participation from multinational pharmaceutical companies and specialized API manufacturers. Competition is driven by cost efficiency, regulatory compliance, capacity scale, and supply reliability.

  • Bristol-Myers Squibb – Early innovator with strong historical presence in antidiabetic drugs
  • Shouguang Fukang Pharmaceutical – Major Chinese supplier with large-scale API production capacity
  • Harman Finochem – Focused on high-quality APIs with global regulatory approvals
  • Vistin Pharma – Specialized producer with strong focus on metformin API
  • CR Double-Crane – Integrated pharmaceutical manufacturer with domestic strength
  • Keyuan Pharmaceutical – Supplier to both domestic and export markets
  • FARMHISPANIA GROUP – European API producer with regulated-market focus
  • Shijiazhuang Polee Pharmaceutical – Strong presence in bulk generic APIs
  • Merck Santé – Emphasis on branded generics and quality formulations
  • Aarti Drugs – Large-scale Indian API exporter with cost leadership
  • Teva – Global leader in generic formulations and APIs
  • Taj API – Niche API producer with focus on regulated markets
  • Wanbury – Integrated API and formulation manufacturer

Regional Market Analysis

Asia-Pacific (Largest Production & High Growth)

  • Dominates global Metformin Hydrochloride production
  • India and China serve as key global API supply hubs
  • Strong domestic demand due to rising diabetes incidence
  • Export-oriented manufacturing strengthens regional leadership

North America

  • Major consumption market driven by high diabetes prevalence
  • Strong demand for generic metformin formulations
  • Market influenced by pricing pressure and regulatory scrutiny

Europe

  • Stable and mature market
  • Preference for high-quality, regulatory-compliant APIs
  • Growing demand for extended-release formulations

Central & South America

  • Emerging demand supported by expanding healthcare access
  • Increasing government procurement of low-cost generics

Middle East & Africa

  • Gradual growth driven by improving healthcare infrastructure
  • High unmet need for affordable diabetes treatment

Competitive and Strategic Outlook

  • Market characterized by high volumes and low margins
  • Regulatory compliance (USFDA, EMA) is a key competitive differentiator
  • Manufacturers focus on capacity optimization, cost reduction, and long-term supply contracts
  • Extended-release and combination therapies present incremental growth opportunities

Executive Summary

The global Metformin Hydrochloride market remains one of the most resilient and volume-driven segments within the pharmaceutical API and generic formulations industry. Metformin Hydrochloride continues to be the first-line therapy for type-2 diabetes mellitus, owing to its proven clinical efficacy, long safety record, affordability, and endorsement in standard treatment guidelines worldwide.

In 2025, the global Metformin Hydrochloride market is valued at XX million US$ and is projected to reach XX million US$ by 2036, growing at a stable CAGR during 2026–2036. Market expansion is primarily supported by the rapid rise in diabetes prevalence, increasing life expectancy, broader access to healthcare in emerging economies, and sustained demand for cost-effective generic drugs.

Production is highly concentrated in Asia-Pacific, particularly India and China, while North America and Europe remain the largest consumption regions. Despite persistent pricing pressure and regulatory compliance costs, Metformin Hydrochloride continues to generate long-term, predictable demand across global healthcare systems.

DRIVERS (Growth Drivers)

  1. Rising Global Diabetes Burden
    Increasing prevalence of type-2 diabetes across both developed and developing economies remains the strongest demand driver.
  2. First-Line Treatment Status
    Metformin Hydrochloride is widely recommended as the initial pharmacological therapy, ensuring consistent prescription volumes.
  3. Strong Generic Penetration
    Off-patent status enables large-scale generic manufacturing, improving affordability and accessibility.
  4. Government Healthcare Programs
    Inclusion of metformin in national essential medicines lists supports large-volume institutional procurement.
  5. Growth in Extended-Release Formulations
    Rising preference for extended-release metformin enhances demand for specialized API grades.

RESTRAINTS (Market Challenges)

  1. Intense Price Competition
    High number of API manufacturers leads to commoditization and margin pressure.
  2. Stringent Regulatory Compliance
    Compliance with USFDA, EMA, and other regulatory authorities increases operational and audit-related costs.
  3. Supply Chain Concentration Risk
    Heavy dependence on a limited number of producing countries exposes the market to geopolitical and logistical risks.
  4. API Quality Scrutiny
    Increasing inspections and warning letters can disrupt supply from non-compliant facilities.

TRENDS (Key Market Trends)

  1. Shift Toward Extended-Release & Combination Therapies
    Combination drugs and ER formulations are gaining preference for improved patient compliance.
  2. Backward Integration by Formulation Players
    Major generic manufacturers are investing in captive API production to secure supply.
  3. Rising Demand from Emerging Markets
    Asia, Africa, and Latin America are witnessing faster volume growth due to expanding diabetic populations.
  4. Process Optimization & Cost Reduction
    Manufacturers are focusing on yield improvement and energy-efficient synthesis routes.
  5. Regulatory-Approved Capacity Expansion
    Capacity additions increasingly target regulated-market compliance rather than volume alone.

OPPORTUNITIES (Future Growth Opportunities)

  1. Untapped Rural & Semi-Urban Markets
    Expanding healthcare penetration creates incremental volume demand.
  2. Growth in Fixed-Dose Combinations
    Metformin combined with DPP-4 inhibitors, SGLT-2 inhibitors, and sulfonylureas offers higher value opportunities.
  3. Expansion of Government Tenders
    Large-scale public procurement programs favor low-cost, high-volume suppliers.
  4. Branded Generics in Emerging Economies
    Branded formulations allow better margins compared to pure commodity APIs.
  5. New Indications & Research
    Ongoing research into metformin’s role in PCOS, obesity, and oncology could expand demand base.

PORTER’S FIVE FORCES ANALYSIS

1. Threat of New Entrants – Moderate

  • API synthesis is well established, but regulatory approvals and capital investment create moderate entry barriers.

2. Bargaining Power of Suppliers – Low to Moderate

  • Raw materials are widely available; however, energy and solvent costs can impact margins.

3. Bargaining Power of Buyers – High

  • Large generic formulators and government procurement agencies exert strong price pressure.

4. Threat of Substitutes – Low

  • No direct therapeutic substitute matches metformin’s cost-effectiveness and safety as first-line therapy.

5. Competitive Rivalry – Very High

  • Numerous global and regional API suppliers compete primarily on price, compliance, and delivery reliability.

SWOT ANALYSIS – KEY PLAYERS

(Key players include Bristol-Myers Squibb, Vistin Pharma, Aarti Drugs, Teva, Harman Finochem)

Strengths

  • Established manufacturing processes with proven scalability
  • Strong regulatory approvals and long-standing customer relationships
  • High-volume production capability ensuring cost leadership
  • Global distribution networks

Weaknesses

  • Thin operating margins due to commoditization
  • High dependency on regulatory compliance outcomes
  • Limited product differentiation at API level

Opportunities

  • Expansion into extended-release and DC-grade APIs
  • Strategic alliances with formulation manufacturers
  • Increased demand from emerging markets
  • Participation in long-term government supply contracts

Threats

  • Aggressive price undercutting by low-cost producers
  • Regulatory actions disrupting production or exports
  • Supply chain disruptions and geopolitical risks
  • Consolidation among buyers increasing negotiation power

Strategic Market Outlook

The Metformin Hydrochloride market will remain volume-driven, price-sensitive, and regulation-centric. Long-term success will depend on cost efficiency, regulatory compliance, supply reliability, and strategic customer relationships. While growth rates are moderate, the market’s predictability and scale make it a cornerstone API segment for global pharmaceutical manufacturers.

Contact us for more details
https://chemreports.com/contact
Explore more report here-
https://chemreports.com/reports

Table of Contents

Global Metformin Hydrochloride Market Professional Survey Report
1 Industry Overview of Metformin Hydrochloride
    1.1 Definition and Specifications of Metformin Hydrochloride
        1.1.1 Definition of Metformin Hydrochloride
        1.1.2 Specifications of Metformin Hydrochloride
    1.2 Classification of Metformin Hydrochloride
        1.2.1 Metformin HCL
        1.2.2 Metformin DC
        1.2.3 Others
    1.3 Applications of Metformin Hydrochloride
        1.3.1 Metformin Hydrochloride Tablets
        1.3.2 Metformin Hydrochloride Extended-Release Tablets
        1.3.3 Others Form
    1.4 Market Segment by Regions
        1.4.1 North America
        1.4.2 Europe
        1.4.3 China
        1.4.4 Japan
        1.4.5 Southeast Asia
        1.4.6 India

2 Manufacturing Cost Structure Analysis of Metformin Hydrochloride
    2.1 Raw Material and Suppliers
    2.2 Manufacturing Cost Structure Analysis of Metformin Hydrochloride
    2.3 Manufacturing Process Analysis of Metformin Hydrochloride
    2.4 Industry Chain Structure of Metformin Hydrochloride

3 Technical Data and Manufacturing Plants Analysis of Metformin Hydrochloride
    3.1 Capacity and Commercial Production Date of Global Metformin Hydrochloride Major Manufacturers
    3.2 Manufacturing Plants Distribution of Global Metformin Hydrochloride Major Manufacturers
    3.3 R&D Status and Technology Source of Global Metformin Hydrochloride Major Manufacturers
    3.4 Raw Materials Sources Analysis of Global Metformin Hydrochloride Major Manufacturers

4 Global Metformin Hydrochloride Overall Market Overview
    4.1 2013-E Overall Market Analysis
    4.2 Capacity Analysis
        4.2.1 2013-E Global Metformin Hydrochloride Capacity and Growth Rate Analysis
        4.2.2 2017 Metformin Hydrochloride Capacity Analysis (Company Segment)
    4.3 Sales Analysis
        4.3.1 2013-E Global Metformin Hydrochloride Sales and Growth Rate Analysis
        4.3.2 2017 Metformin Hydrochloride Sales Analysis (Company Segment)
    4.4 Sales Price Analysis
        4.4.1 2013-E Global Metformin Hydrochloride Sales Price
        4.4.2 2017 Metformin Hydrochloride Sales Price Analysis (Company Segment)

5 Metformin Hydrochloride Regional Market Analysis
    5.1 North America Metformin Hydrochloride Market Analysis
        5.1.1 North America Metformin Hydrochloride Market Overview
        5.1.2 North America 2013-E Metformin Hydrochloride Local Supply, Import, Export, Local Consumption Analysis
        5.1.3 North America 2013-E Metformin Hydrochloride Sales Price Analysis
        5.1.4 North America 2017 Metformin Hydrochloride Market Share Analysis
    5.2 Europe Metformin Hydrochloride Market Analysis
        5.2.1 Europe Metformin Hydrochloride Market Overview
        5.2.2 Europe 2013-E Metformin Hydrochloride Local Supply, Import, Export, Local Consumption Analysis
        5.2.3 Europe 2013-E Metformin Hydrochloride Sales Price Analysis
        5.2.4 Europe 2017 Metformin Hydrochloride Market Share Analysis
    5.3 China Metformin Hydrochloride Market Analysis
        5.3.1 China Metformin Hydrochloride Market Overview
        5.3.2 China 2013-E Metformin Hydrochloride Local Supply, Import, Export, Local Consumption Analysis
        5.3.3 China 2013-E Metformin Hydrochloride Sales Price Analysis
        5.3.4 China 2017 Metformin Hydrochloride Market Share Analysis
    5.4 Japan Metformin Hydrochloride Market Analysis
        5.4.1 Japan Metformin Hydrochloride Market Overview
        5.4.2 Japan 2013-E Metformin Hydrochloride Local Supply, Import, Export, Local Consumption Analysis
        5.4.3 Japan 2013-E Metformin Hydrochloride Sales Price Analysis
        5.4.4 Japan 2017 Metformin Hydrochloride Market Share Analysis
    5.5 Southeast Asia Metformin Hydrochloride Market Analysis
        5.5.1 Southeast Asia Metformin Hydrochloride Market Overview
        5.5.2 Southeast Asia 2013-E Metformin Hydrochloride Local Supply, Import, Export, Local Consumption Analysis
        5.5.3 Southeast Asia 2013-E Metformin Hydrochloride Sales Price Analysis
        5.5.4 Southeast Asia 2017 Metformin Hydrochloride Market Share Analysis
    5.6 India Metformin Hydrochloride Market Analysis
        5.6.1 India Metformin Hydrochloride Market Overview
        5.6.2 India 2013-E Metformin Hydrochloride Local Supply, Import, Export, Local Consumption Analysis
        5.6.3 India 2013-E Metformin Hydrochloride Sales Price Analysis
        5.6.4 India 2017 Metformin Hydrochloride Market Share Analysis

6 Global 2013-E Metformin Hydrochloride Segment Market Analysis (by Type)
    6.1 Global 2013-E Metformin Hydrochloride Sales by Type
    6.2 Different Types of Metformin Hydrochloride Product Interview Price Analysis
    6.3 Different Types of Metformin Hydrochloride Product Driving Factors Analysis
        6.3.1 Metformin HCL Growth Driving Factor Analysis
        6.3.2 Metformin DC Growth Driving Factor Analysis
        6.3.3 Others Growth Driving Factor Analysis

7 Global 2013-E Metformin Hydrochloride Segment Market Analysis (by Application)
    7.1 Global 2013-E Metformin Hydrochloride Consumption by Application
    7.2 Different Application of Metformin Hydrochloride Product Interview Price Analysis
    7.3 Different Application of Metformin Hydrochloride Product Driving Factors Analysis
        7.3.1 Metformin Hydrochloride Tablets of Metformin Hydrochloride Growth Driving Factor Analysis
        7.3.2 Metformin Hydrochloride Extended-Release Tablets of Metformin Hydrochloride Growth Driving Factor Analysis
        7.3.3 Others Form of Metformin Hydrochloride Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Metformin Hydrochloride
    8.1 Bristol-Mayers Squibb
        8.1.1 Company Profile
        8.1.2 Product Picture and Specifications
            8.1.2.1 Product A
            8.1.2.2 Product B
        8.1.3 Bristol-Mayers Squibb 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.1.4 Bristol-Mayers Squibb 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.2 Shouguang Fukang Pharmaceutical
        8.2.1 Company Profile
        8.2.2 Product Picture and Specifications
            8.2.2.1 Product A
            8.2.2.2 Product B
        8.2.3 Shouguang Fukang Pharmaceutical 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.2.4 Shouguang Fukang Pharmaceutical 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.3 Harman Finochem
        8.3.1 Company Profile
        8.3.2 Product Picture and Specifications
            8.3.2.1 Product A
            8.3.2.2 Product B
        8.3.3 Harman Finochem 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.3.4 Harman Finochem 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.4 Vistin Pharma
        8.4.1 Company Profile
        8.4.2 Product Picture and Specifications
            8.4.2.1 Product A
            8.4.2.2 Product B
        8.4.3 Vistin Pharma 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.4.4 Vistin Pharma 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.5 CR Double-Crane
        8.5.1 Company Profile
        8.5.2 Product Picture and Specifications
            8.5.2.1 Product A
            8.5.2.2 Product B
        8.5.3 CR Double-Crane 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.5.4 CR Double-Crane 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.6 Keyuan Pharmaceutical
        8.6.1 Company Profile
        8.6.2 Product Picture and Specifications
            8.6.2.1 Product A
            8.6.2.2 Product B
        8.6.3 Keyuan Pharmaceutical 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.6.4 Keyuan Pharmaceutical 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.7 FARMHISPANIA GROUP
        8.7.1 Company Profile
        8.7.2 Product Picture and Specifications
            8.7.2.1 Product A
            8.7.2.2 Product B
        8.7.3 FARMHISPANIA GROUP 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.7.4 FARMHISPANIA GROUP 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.8 Shijiazhuang Polee Pharmaceutical
        8.8.1 Company Profile
        8.8.2 Product Picture and Specifications
            8.8.2.1 Product A
            8.8.2.2 Product B
        8.8.3 Shijiazhuang Polee Pharmaceutical 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.8.4 Shijiazhuang Polee Pharmaceutical 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.9 Merck Sante
        8.9.1 Company Profile
        8.9.2 Product Picture and Specifications
            8.9.2.1 Product A
            8.9.2.2 Product B
        8.9.3 Merck Sante 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.9.4 Merck Sante 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.10 Aarti Drugs
        8.10.1 Company Profile
        8.10.2 Product Picture and Specifications
            8.10.2.1 Product A
            8.10.2.2 Product B
        8.10.3 Aarti Drugs 2017 Metformin Hydrochloride Sales, Ex-factory Price, Revenue, Gross Margin Analysis
        8.10.4 Aarti Drugs 2017 Metformin Hydrochloride Business Region Distribution Analysis
    8.11 TEVA
    8.12 Taj API
    8.13 Wanbury

9 Development Trend of Analysis of Metformin Hydrochloride Market
    9.1 Global Metformin Hydrochloride Market Trend Analysis
        9.1.1 Global -2025 Metformin Hydrochloride Market Size (Volume and Value) Forecast
        9.1.2 Global -2025 Metformin Hydrochloride Sales Price Forecast
    9.2 Metformin Hydrochloride Regional Market Trend
        9.2.1 North America -2025 Metformin Hydrochloride Consumption Forecast
        9.2.2 Europe -2025 Metformin Hydrochloride Consumption Forecast
        9.2.3 China -2025 Metformin Hydrochloride Consumption Forecast
        9.2.4 Japan -2025 Metformin Hydrochloride Consumption Forecast
        9.2.5 Southeast Asia -2025 Metformin Hydrochloride Consumption Forecast
        9.2.6 India -2025 Metformin Hydrochloride Consumption Forecast
    9.3 Metformin Hydrochloride Market Trend (Product Type)
    9.4 Metformin Hydrochloride Market Trend (Application)

10 Metformin Hydrochloride Marketing Type Analysis
    10.1 Metformin Hydrochloride Regional Marketing Type Analysis
    10.2 Metformin Hydrochloride International Trade Type Analysis
    10.3 Traders or Distributors with Contact Information of Metformin Hydrochloride by Region
    10.4 Metformin Hydrochloride Supply Chain Analysis

11 Consumers Analysis of Metformin Hydrochloride
    11.1 Consumer 1 Analysis
    11.2 Consumer 2 Analysis
    11.3 Consumer 3 Analysis
    11.4 Consumer 4 Analysis

12 Conclusion of the Global Metformin Hydrochloride Market Professional Survey Report 2017
    Methodology
    Analyst Introduction
    Data Source
List of Tables and Figures
    Figure Picture of Metformin Hydrochloride
    Table Product Specifications of Metformin Hydrochloride
    Table Classification of Metformin Hydrochloride
    Figure Global Production Market Share of Metformin Hydrochloride by Type
    Figure Metformin HCL Picture
    Table Major Manufacturers of Metformin HCL
    Figure Metformin DC Picture
    Table Major Manufacturers of Metformin DC
    Figure Others Picture
    Table Major Manufacturers of Others
    Table Applications of Metformin Hydrochloride
    Figure Global Consumption Volume Market Share of Metformin Hydrochloride by Application
    Figure Metformin Hydrochloride Tablets Examples
    Table Major Consumers in Metformin Hydrochloride Tablets
    Figure Metformin Hydrochloride Extended-Release Tablets Examples
    Table Major Consumers in Metformin Hydrochloride Extended-Release Tablets
    Figure Others Form Examples
    Table Major Consumers in Others Form
    Figure Market Share of Metformin Hydrochloride by Regions
    Figure North America Metformin Hydrochloride Market Size (Million USD) (2013-2025)
    Figure Europe Metformin Hydrochloride Market Size (Million USD) (2013-2025)
    Figure China Metformin Hydrochloride Market Size (Million USD) (2013-2025)
    Figure Japan Metformin Hydrochloride Market Size (Million USD) (2013-2025)
    Figure Southeast Asia Metformin Hydrochloride Market Size (Million USD) (2013-2025)
    Figure India Metformin Hydrochloride Market Size (Million USD) (2013-2025)
    Table Metformin Hydrochloride Raw Material and Suppliers
    Table Manufacturing Cost Structure Analysis of Metformin Hydrochloride
    Figure Manufacturing Process Analysis of Metformin Hydrochloride
    Figure Industry Chain Structure of Metformin Hydrochloride
    Table Capacity and Commercial Production Date of Global Metformin Hydrochloride Major Manufacturers
    Table Manufacturing Plants Distribution of Global Metformin Hydrochloride Major Manufacturers
    Table R&D Status and Technology Source of Global Metformin Hydrochloride Major Manufacturers
    Table Raw Materials Sources Analysis of Global Metformin Hydrochloride Major Manufacturers
    Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Metformin Hydrochloride 2013-E
    Figure Global 2013-E Metformin Hydrochloride Market Size (Volume) and Growth Rate
    Figure Global 2013-E Metformin Hydrochloride Market Size (Value) and Growth Rate
    Table 2013-E Global Metformin Hydrochloride Capacity and Growth Rate
    Table 2017 Global Metformin Hydrochloride Capacity (K MT) List (Company Segment)
    Table 2013-E Global Metformin Hydrochloride Sales (K MT) and Growth Rate
    Table 2017 Global Metformin Hydrochloride Sales (K MT) List (Company Segment)
    Table 2013-E Global Metformin Hydrochloride Sales Price (USD/MT)
    Table 2017 Global Metformin Hydrochloride Sales Price (USD/MT) List (Company Segment)
    Figure North America Capacity Overview
    Table North America Supply, Import, Export and Consumption (K MT) of Metformin Hydrochloride 2013-E
    Figure North America 2013-E Metformin Hydrochloride Sales Price (USD/MT)
    Figure North America 2017 Metformin Hydrochloride Sales Market Share
    Figure Europe Capacity Overview
    Table Europe Supply, Import, Export and Consumption (K MT) of Metformin Hydrochloride 2013-E
    Figure Europe 2013-E Metformin Hydrochloride Sales Price (USD/MT)
    Figure Europe 2017 Metformin Hydrochloride Sales Market Share
    Figure China Capacity Overview
    Table China Supply, Import, Export and Consumption (K MT) of Metformin Hydrochloride 2013-E
    Figure China 2013-E Metformin Hydrochloride Sales Price (USD/MT)
    Figure China 2017 Metformin Hydrochloride Sales Market Share
    Figure Japan Capacity Overview
    Table Japan Supply, Import, Export and Consumption (K MT) of Metformin Hydrochloride 2013-E
    Figure Japan 2013-E Metformin Hydrochloride Sales Price (USD/MT)
    Figure Japan 2017 Metformin Hydrochloride Sales Market Share
    Figure Southeast Asia Capacity Overview
    Table Southeast Asia Supply, Import, Export and Consumption (K MT) of Metformin Hydrochloride 2013-E
    Figure Southeast Asia 2013-E Metformin Hydrochloride Sales Price (USD/MT)
    Figure Southeast Asia 2017 Metformin Hydrochloride Sales Market Share
    Figure India Capacity Overview
    Table India Supply, Import, Export and Consumption (K MT) of Metformin Hydrochloride 2013-E
    Figure India 2013-E Metformin Hydrochloride Sales Price (USD/MT)
    Figure India 2017 Metformin Hydrochloride Sales Market Share
    Table Global 2013-E Metformin Hydrochloride Sales (K MT) by Type
    Table Different Types Metformin Hydrochloride Product Interview Price
    Table Global 2013-E Metformin Hydrochloride Sales (K MT) by Application
    Table Different Application Metformin Hydrochloride Product Interview Price
    Table Bristol-Mayers Squibb Information List
    Table Product Overview
    Table 2017 Bristol-Mayers Squibb Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 Bristol-Mayers Squibb Metformin Hydrochloride Business Region Distribution
    Table Shouguang Fukang Pharmaceutical Information List
    Table Product Overview
    Table 2017 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Business Region Distribution
    Table Harman Finochem Information List
    Table Product Overview
    Table 2017 Harman Finochem Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 Harman Finochem Metformin Hydrochloride Business Region Distribution
    Table Vistin Pharma Information List
    Table Product Overview
    Table 2017 Vistin Pharma Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 Vistin Pharma Metformin Hydrochloride Business Region Distribution
    Table CR Double-Crane Information List
    Table Product Overview
    Table 2017 CR Double-Crane Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 CR Double-Crane Metformin Hydrochloride Business Region Distribution
    Table Keyuan Pharmaceutical Information List
    Table Product Overview
    Table 2017 Keyuan Pharmaceutical Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 Keyuan Pharmaceutical Metformin Hydrochloride Business Region Distribution
    Table FARMHISPANIA GROUP Information List
    Table Product Overview
    Table 2017 FARMHISPANIA GROUP Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 FARMHISPANIA GROUP Metformin Hydrochloride Business Region Distribution
    Table Shijiazhuang Polee Pharmaceutical Information List
    Table Product Overview
    Table 2017 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Business Region Distribution
    Table Merck Sante Information List
    Table Product Overview
    Table 2017 Merck Sante Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 Merck Sante Metformin Hydrochloride Business Region Distribution
    Table Aarti Drugs Information List
    Table Product Overview
    Table 2017 Aarti Drugs Metformin Hydrochloride Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
    Figure 2017 Aarti Drugs Metformin Hydrochloride Business Region Distribution
    Table TEVA Information List
    Table Taj API Information List
    Table Wanbury Information List
    Figure Global -2025 Metformin Hydrochloride Market Size (K MT) and Growth Rate Forecast
    Figure Global -2025 Metformin Hydrochloride Market Size (Million USD) and Growth Rate Forecast
    Figure Global -2025 Metformin Hydrochloride Sales Price (USD/MT) Forecast
    Figure North America -2025 Metformin Hydrochloride Consumption Volume (K MT) and Growth Rate Forecast
    Figure China -2025 Metformin Hydrochloride Consumption Volume (K MT) and Growth Rate Forecast
    Figure Europe -2025 Metformin Hydrochloride Consumption Volume (K MT) and Growth Rate Forecast
    Figure Southeast Asia -2025 Metformin Hydrochloride Consumption Volume (K MT) and Growth Rate Forecast
    Figure Japan -2025 Metformin Hydrochloride Consumption Volume (K MT) and Growth Rate Forecast
    Figure India -2025 Metformin Hydrochloride Consumption Volume (K MT) and Growth Rate Forecast
    Table Global Sales Volume (K MT) of Metformin Hydrochloride by Type -2025
    Table Global Consumption Volume (K MT) of Metformin Hydrochloride by Application -2025
    Table Traders or Distributors with Contact Information of Metformin Hydrochloride by Region

Market Segmentation Analysis

By Product Type

Metformin HCl

  • Core API form used in immediate-release formulations
  • Represents the largest share of global volume consumption
  • High demand from generic tablet manufacturers

Metformin DC (Direct Compression)

  • Pre-processed grade designed for direct tablet compression
  • Enables improved manufacturing efficiency and reduced processing time
  • Increasing adoption among large-scale formulators

Others

  • Includes customized grades and specialty forms
  • Used for specific formulation or regional regulatory requirements

By Application

Metformin Hydrochloride Tablets

  • Dominant application segment
  • High prescription volumes across both developed and developing markets
  • Strong demand from government tenders and public healthcare programs

Metformin Hydrochloride Extended-Release Tablets

  • Fast-growing segment
  • Improved patient compliance and reduced gastrointestinal side effects
  • Increasing preference in chronic diabetes management

Other Forms

  • Includes combination therapies and alternative dosage forms
  • Used in multi-drug diabetes treatment regimens

Key Players Analysis

The Metformin Hydrochloride market is highly competitive and price-sensitive, with participation from multinational pharmaceutical companies and specialized API manufacturers. Competition is driven by cost efficiency, regulatory compliance, capacity scale, and supply reliability.

  • Bristol-Myers Squibb – Early innovator with strong historical presence in antidiabetic drugs
  • Shouguang Fukang Pharmaceutical – Major Chinese supplier with large-scale API production capacity
  • Harman Finochem – Focused on high-quality APIs with global regulatory approvals
  • Vistin Pharma – Specialized producer with strong focus on metformin API
  • CR Double-Crane – Integrated pharmaceutical manufacturer with domestic strength
  • Keyuan Pharmaceutical – Supplier to both domestic and export markets
  • FARMHISPANIA GROUP – European API producer with regulated-market focus
  • Shijiazhuang Polee Pharmaceutical – Strong presence in bulk generic APIs
  • Merck Santé – Emphasis on branded generics and quality formulations
  • Aarti Drugs – Large-scale Indian API exporter with cost leadership
  • Teva – Global leader in generic formulations and APIs
  • Taj API – Niche API producer with focus on regulated markets
  • Wanbury – Integrated API and formulation manufacturer

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.